UNSPSC 51461521: Balsam peru

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers 8P5F881OCY (basic) and DIK0395679 (the viscous chemically-neutral liquid thereof), which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 530967 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Rosanae, Order Fabales, Family Fabaceae, Genus Myroxylon L. f., Species Myroxylon balsamum (L.), Variety Myroxylon balsamum var. pereirae, more commonly known as MYROXYLON or, as here, BALSAM OF PERU.

UNSPSC 51461521 Balsam peru is a Commodity code for specialty pharmaceutical and botanical products sourced through state and local cooperative purchasing arrangements. State and local governments procure these products primarily through multistate cooperative alliances that consolidate demand across participating jurisdictions and establish master vendor agreements with authorized wholesalers. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body for recent activity under this code, procuring generic pharmaceuticals and over-the-counter products on behalf of member states and local facilities. Procurement under this code requires vendors to hold current Good Manufacturing Practices (cGMP) certification and Drug Supply Chain Security Act (DSCSA) compliance, maintain contractual relationships with designated authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., and demonstrate pricing flexibility through flat-price, net-price, or WAC-minus structures. Vendors must carry comprehensive insurance including commercial general liability of $5 million per occurrence and network security and privacy liability of $2 million, and all products must meet FDA requirements with minimum one-year expiration dates and six-month shelf lives.

MMCAP's geographic footprint spans Minnesota and Oregon as participating jurisdictions. The Minnesota Department of Administration issued an RFP (S1070000015802) on January 20, 2026 to establish multiple contracts for generic pharmaceuticals and OTC products, with proposals due March 26, 2026 and evaluation weighted heavily toward price competitiveness (75 percent), followed by fixed pricing for the contract term (10 percent), compliance with administrative data formats (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). Awarded vendors will become effective July 1, 2026, with contract terms of two years for new responders and optional extensions thereafter. This cooperative purchasing model concentrates procurement authority at the state level while distributing products across multiple state and local facilities.